MyFinsight
Home
Blog
About
Contact
Download
Download image
Issuance of common stock
in connection with...
$5,650K
Issuance of common stock
in connection with...
$2,174K
Issuance of common stock
in connection with...
$1,997K
Net cash provided by
(used in) financing...
$9,714K
Effect of exchange rate
changes on cash and cash...
$2K
Canceled cashflow
$107K
Net increase
(decrease) in cash, cash...
$3,517K
Canceled cashflow
$6,199K
Payments on
insurancepremiumloan
-$107K
Accounts payable
$433K
Stock-based compensation
$312K
Depreciation and
amortization
$130K
Non-cash lease expense
$34K
Net cash used in
operating activities
-$6,196K
Net cash used in
investing activities
-$3K
Canceled cashflow
$909K
Net loss
-$6,780K
Purchases of property and
equipment
$3K
Prepaid expenses and
other assets
$141K
Accrued expenses
-$125K
R&d tax credit
incentive receivable
$43K
Accrued compensation
expenses
-$16K
Back
Back
Cash Flow
source: myfinsight.com
Vivani Medical, Inc. (VANI)
Vivani Medical, Inc. (VANI)